Competition Markets Authority
Statutory timetable
| Date | Action |
|---|---|
| 17 March 2023 | Decision announced |
| 20 January 2023 | Launch of merger inquiry |
| 20 January 2023 to 3 February 2023 | Invitation to comment |
Phase 1
Reference unless undertakings accepted
17 March 2023: The CMA has decided, on the information currently available to it, that it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom. This merger will be referred for a phase 2 investigation unless the parties offer acceptable undertakings to address these competition concerns.
-
(17.3.23)
-
Press release: Healthcare deal could lead to higher costs for NHS (17.3.23)
Launch of merger inquiry
20 January 2023: The CMA announced the launch of its merger inquiry by notice to the parties.
- (20.1.23)
Invitation to comment: closed
20 January 2023: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2022 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
To assist it with this assessment, the CMA invites comments on the transaction from any interested party.
These comments should be provided by the deadline set out above.
Contact
Please send written representations about any competition or public interest issues to:
Adnan Farook, adnan.farook@cma.gov.uk